Altered expression of CD44 and DKK1 in the progression of Barrett's esophagus to esophageal adenocarcinoma

Virchows Archiv

Volumn 454, Issue 6, 2009, Pages 629-637

  Darlavoix, T ^a   Seelentag, W ^b   Yan, P ^c   Bachmann, A ^c   Bosman, F T ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Unilabs   (France)

^c UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

Barrett's esophagus; Dysplasia; Esophageal adenocarcinoma

Indexed keywords

BETA CATENIN; CYCLOOXYGENASE 2; DICKKOPF 1 PROTEIN; HERMES ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR SOX9; UVOMORULIN;

ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER RISK; CLINICAL ARTICLE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADENOCARCINOMA; ANTIGENS, CD44; BARRETT ESOPHAGUS; CYCLOOXYGENASE 2; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PRECANCEROUS CONDITIONS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 67649105394     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0769-z     Document Type: Article

References (46)

1. JF Flejou 2000 Barrett's oesophagus: from metaplasia to dysplasia and cancer Gut 54 Suppl 1 i6 i12
2. LB Koppert BP Wijnhoven H van Dekken 2005 The molecular biology of esophageal adenocarcinoma J Surg Oncol 92 169 190 (Pubitemid 41779299)
3. RJ Playford 2006 New British society of gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus Gut 55 442
4. HB el-Serag A Sonnenberg 1998 Opposing time trends of peptic ulcer and reflux disease Gut 43 327 333 (Pubitemid 28414912)
5. WJ Blot JK McLaughlin 1999 The changing epidemiology of esophageal cancer Semin Oncol 26 5 Suppl 15 2 8 (Pubitemid 29529530)
6. DC Farrow TL Vaughan 1996 Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States) Cancer Causes Control 7 322 327 (Pubitemid 26163884)
7. GW Falk TW Rice JR Goldblum 1999 Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia Gastrointest Endosc 49 170 176 (Pubitemid 29111309)
8. RF Heitmiller M Redmond SR Hamilton 1996 Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy Ann Surg 224 66 71 (Pubitemid 26227409)
9. NJ Shaheen MA Crosby EM Bozymski 2000 Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 119 333 338 (Pubitemid 30621983)
10. JF Flejou M Svrcek 2007 Barrett's oesophagus-a pathologist's view Histopathology 50 3 14
11. CP Morales RF Souza SJ Spechler 2002 Hallmarks of cancer progression in Barrett's oesophagus Lancet 360 1587 1589 (Pubitemid 35356377)
12. G Clement R Braunschweig N Pasquier 2006 Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus Oncogene 25 3084 3092 (Pubitemid 43780474)
13. H Doucas G Garcea CP Neal 2005 Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance Eur J Cancer 41 365 379 (Pubitemid 40187207)
14. XY Shi B Bhagwandeen AS Leong 2008 p16, Cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett esophagus Appl Immunohistochem Mol Morphol 16 447 452
15. XY Shi B Bhagwandeen AS Leong 2008 CDX2 and villin are useful markers of intestinal metaplasia in the diagnosis of Barrett esophagus Am J Clin Pathol 129 571 577 (Pubitemid 352029276)
16. KS Nair R Naidoo R Chetty 2005 Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value J Clin Pathol 58 343 351 (Pubitemid 40516162)
17. MM Taketo 2006 Wnt signaling and gastrointestinal tumorigenesis in mouse models Oncogene 25 7522 7530 (Pubitemid 44885751)
18. R Okamoto M Watanabe 2004 Molecular and clinical basis for the regeneration of human gastrointestinal epithelia J Gastroenterol 39 1 6 (Pubitemid 38208235)
19. ML Johnson N Rajamannan 2006 Diseases of Wnt signaling Rev Endocr Metab Disord 7 41 49 (Pubitemid 46044348)
20. JH van Es ME van Gijn O Riccio 2005 Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells Nature 435 959 963 (Pubitemid 40896322)
21. R Almeida J Almeida M Shoshkes 2005 OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells J Pathol 207 396 401 (Pubitemid 43025687)
22. YS Bian MC Osterheld C Fontolliet 2002 p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus Gastroenterology 122 1113 1121 (Pubitemid 34267292)
23. H Brantjes N Barker J van Es 2002 TCF: lady justice casting the final verdict on the outcome of Wnt signalling Biol Chem 383 255 261 (Pubitemid 34229127)
24. P Yan W Seelentag A Bachmann 2007 An agarose matrix facilitates sectioning of tissue microarray blocks J Histochem Cytochem 55 21 24 (Pubitemid 46032612)
25. V Villanacci E Rossi C Zambelli 2007 COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus Dig Liver Dis 39 305 311 (Pubitemid 46432252)
26. T Bailey L Biddlestone N Shepherd 1998 Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation Am J Pathol 152 135 144 (Pubitemid 28028054)
27. D Pinto H Clevers 2005 Wnt, stem cells and cancer in the intestine Biol Cell 97 185 196 (Pubitemid 40360891)
28. H Clevers E Batlle 2006 EphB/EphrinB receptors and Wnt signaling in colorectal cancer Cancer Res 66 2 5 (Pubitemid 43165998)
29. A Gregorieff D Pinto H Begthel 2005 Expression pattern of Wnt signaling components in the adult intestine Gastroenterology 129 626 638 (Pubitemid 41096648)
30. H Mutoh H Sakamoto H Hayakawa 2006 The intestine-specific homeobox gene Cdx2 induces expression of the basic helix-loop-helix transcription factor Math1 Differentiation 74 313 321 (Pubitemid 43945783)
31. T Liu X Zhang CK So 2007 Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells Carcinogenesis 28 488 496 (Pubitemid 46321867)
32. DM Greenawalt C Duong GK Smyth 2007 Gene expression profiling of esophageal cancer: comparative analysis of Barrett's esophagus, adenocarcinoma, and squamous cell carcinoma Int J Cancer 120 1914 1921 (Pubitemid 46418367)
33. CY Ngan H Yamamoto I Seshimo 1996 Expression of CD44H and CD44v3 in normal oesophagus, Barrett mucosa and oesophageal carcinoma J Clin Pathol 49 489 492
34. C Lagorce-Pages F Paraf 1998 Expression of CD44 in premalignant and malignant Barrett's oesophagus Histopathology 32 7 14
35. M Menges R Goebel W Pueschel 2002 Expression of CD44v5 and -v6 in Barrett's carcinoma is not increased compared to that in nondysplastic Barrett's mucosa Exp Mol Pathol 72 207 212 (Pubitemid 34941279)
36. C Niehrs 2006 Function and biological roles of the Dickkopf family of Wnt modulators Oncogene 25 7469 7481 (Pubitemid 44885746)
37. H Sato H Suzuki M Toyota 2007 Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors Carcinogenesis 28 2459 2466 (Pubitemid 350238947)
38. O Aguilera MF Fraga E Ballestar 2006 Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer Oncogene 25 4116 4121 (Pubitemid 44024874)
39. I Ali P Rafiee WJ Hogan 2006 Dickkopf homologs in squamous mucosa of esophagitis patients are overexpressed compared with Barrett's patients and healthy controls Am J Gastroenterol 101 1437 1448 (Pubitemid 43980614)
40. JW Van Baal A Bozikas R Pronk 2008 Cytokeratin and CDX-2 expression in Barrett's esophagus Scand J Gastroenterol 43 132 140 (Pubitemid 351161518)
41. M Wegner 1999 From head to toes: the multiple facets of Sox proteins Nucleic Acids Res 27 1409 1420 (Pubitemid 29206280)
42. P Blache M van de Wetering I Duluc 2004 SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes J Cell Biol 166 37 47 (Pubitemid 38931915)
43. HR Ferguson CP Wild LA Anderson 2008 Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma Cancer Epidemiol Biomarkers Prev 17 727 731
44. M Feith HJ Stein J Mueller 2004 Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53 Dis Esophagus 17 322 327 (Pubitemid 40123809)
45. BP Wijnhoven F Nollet NJ De Both 2000 Genetic alterations involving exon 3 of the beta-catenin gene do not play a role in adenocarcinomas of the esophagus Int J Cancer 86 533 537 (Pubitemid 30249735)
46. LJ Williams DL Guernsey AG Casson 2006 Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma Curr Oncol 13 33 43